Physician profile
John R Holt
NPI 1720283187
$7,109.21
in general payments reported to CMS, 2019-2025
39 companies · $765 in 2025
The $765 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,044 · 2020: $349 · 2021: $999 · 2022: $1,060 · 2023: $846 · 2024: $1,047 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,593 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,593.40 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $999.08 | 2019-2022 | |
| Amgen INC. | $834.34 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $833.67 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $583.13 | 2019-2025 | Farxiga, Andexxa, Brilinta |
| Janssen Pharmaceuticals, INC | $479.12 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $390.64 | 2021-2025 | Verquvo |
| Pfizer INC. | $380.44 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $272.77 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.83 | 2019-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $199.27 | 2019-2025 | Eliquis, Camzyos |
| Irhythm Technologies, INC. | $195.52 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Amarin Pharma, INC. | $179.96 | 2021-2022 | |
| Esperion Therapeutics, INC. | $163.60 | 2020-2022 | |
| Abbott Laboratories | $122.53 | 2022-2023 | Pressurewire, Nc Trek Neo |
| Boston Scientific Corporation | $109.87 | 2020-2025 | Bodyguardian, Lux-Dx Insertable Cardiac Monitor |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $105.92 | 2019-2025 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $103.79 | 2022-2025 | |
| Chiesi USA, INC. | $97.61 | 2019-2025 | Kengreal, Cleviprex |
| Alnylam Pharmaceuticals INC. | $95.56 | 2021-2025 | Onpattro |
| Inari Medical, INC. | $77.04 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $76.73 | 2019-2024 | Opsumit, Uptravi |
| Teleflex LLC | $66.98 | 2024 | Turnpike |
| Baxter Healthcare | $58.89 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Lundbeck LLC | $45.20 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $45.19 | 2023-2024 | Inpefa |
| Elutia, INC. | $43.40 | 2020-2023 | |
| Vifor Pharma, INC. | $42.49 | 2021 | |
| Edwards Lifesciences Corporation | $42.34 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Philips North America LLC | $32.54 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $28.92 | 2019 | |
| Genzyme Corporation | $26.84 | 2019 | |
| Medtronic, INC. | $25.71 | 2022 | |
| Astellas Pharma US INC | $25.45 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $25.09 | 2019 | |
| Medtronic Vascular, INC. | $18.58 | 2020 | |
| Heartflow, INC. | $17.92 | 2025 | |
| Acist Medical Systems, INC. | $16.28 | 2019 | |
| Impulse Dynamics (USA) INC. | $15.38 | 2023 | Optimizer |
| Inspire Medical Systems, INC. | $13.59 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Holt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.